← All trials
NCT06992141
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 24, 2025
- Primary completion
- Nov 30, 2026
- Completion date
- Jun 30, 2027
- First posted
- May 28, 2025
- Last posted
- Sep 22, 2025
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Murdoch UniversityLead sponsor
- University of AucklandCollaborator
- University of WollongongCollaborator
- Duke UniversityCollaborator
- University of QueenslandCollaborator
- Free University of BrusselsCollaborator
- University of California, San DiegoCollaborator
- Monash UniversityCollaborator
- Leducq FoundationCollaborator
- Murdoch UniversityOfficial
- National Health and Medical Research Council, AustraliaCollaborator
- University of MelbourneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.